Product nameAnti-CDK11B antibody - N-terminal
DescriptionRabbit polyclonal to CDK11B - N-terminal
Tested applicationsSuitable for: IHC-P, WBmore details
Species reactivityReacts with: Mouse, Human
Synthetic peptide corresponding to Human CDK11B (N terminal). NP_277021.
Database link: P21127-2
- HeLa, HepG2, lovo and Human colon cancer lysates; Human liver cancer tissue.
Storage instructionsShipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C long term. Avoid freeze / thaw cycle.
Storage bufferpH: 7.3
Preservative: 0.05% Sodium azide
Constituents: 49% PBS, 50% Glycerol
Concentration information loading...
PurityImmunogen affinity purified
Our Abpromise guarantee covers the use of ab198813 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|IHC-P||1/50 - 1/200.|
|WB||1/500 - 1/2000. Predicted molecular weight: 91 kDa.|
RelevanceAppears to play multiple roles in cell cycle progression, cytokinesis and apoptosis. The p110 isoforms have been suggested to be involved in pre-mRNA splicing, potentially by phosphorylating the splicing protein SFRS7. The p58 isoform may act as a negative regulator of normal cell cycle progression.
Cellular localizationCytoplasmic and Nuclear
- CDC2L1 antibody
- CDK11 antibody
- Cell division cycle 2-like protein kinase 1 antibody
All lanes : Anti-CDK11B antibody - N-terminal (ab198813) at 1/750 dilution
Lane 1 : HeLa cell lysate
Lane 2 : HepG2 cell lysate
Lane 3 : Lovo cell lysate
Lane 4 : Human colon cancer tissue lysate
Lysates/proteins at 40 µg per lane.
Predicted band size: 91 kDa
Exposure time: 1 minute
Immunohistochemical analysis of paraffin-embedded Human liver cancer tissue labeling CDK11B with ab198813 at 1/40 dilution
ab198813 has not yet been referenced specifically in any publications.